‪Anthi Maslarinou‬ - ‪Google Scholar‬

Get my own profile

Cited by

	All	Since 2019
Citations	10	10
h-index	2	2
i10-index	0	0

0

6

3

202320245 5

Co-authors

Vangelis ManolopoulosProfessor of Pharmacology, Pharmacogenomics, and Precision Medicine, Democritus University of ThraceVerified email at med.duth.gr
Natalia AtzemianPhD Student, University of ZurichVerified email at uzh.ch

Anthi Maslarinou

Anthi Maslarinou

Researcher, Democritus University of Thrace

Verified email at med.duth.gr - Homepage

Pharmacogenomics Epigenomics Cardiovascular Pharmacology Cancer Pharmacogenomics


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm? A Maslarinou, VG Manolopoulos, G Ragia Frontiers in Pharmacology 14, 1184523, 2023	5	2023
Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece G Ragia, A Maslarinou, N Atzemian, E Biziota, T Koukaki, C Ioannou, ... Frontiers in Pharmacology 14, 1248898, 0	3
SLCO1B1 c. 521T> C gene polymorphism decreases hypoglycemia risk in sulfonylurea-treated type 2 diabetic patients G Ragia, N Atzemian, A Maslarinou, VG Manolopoulos Drug Metabolism and Personalized Therapy 37 (4), 347-352, 2022	2	2022
Effect of therapy with direct oral anticoagulants on PITX2 gene methylation in atrial fibrillation patients A Maslarinou, G Ragia, T Thomopoulos, N Dovrolis, G Kolios, A Trikas, ... EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 78 (SUPPL 1), S40-S40, 2022		2022

The system can't perform the operation now. Try again later.

Articles 1–4